Beilstein J. Org. Chem.2026,22, 771–781, doi:10.3762/bjoc.22.59
. Compound Z8, which acts on both targets, was found to more potently reduce intracellular lipid droplet accumulation in OA-treated HepG2 cells than the FXR agonist GW4064 and the ASK1 inhibitor selonsertib (GS-4997).
Keywords: ASK1 inhibitors; FXR agonists; FXR/ASK1dual-targetmodulators; MASH
PDF
Graphical Abstract
Scheme 1:
Steroidal and nonsteroidal FXR agonists.